Institutional
August 9, 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Back
Share:
Last related news
February 14, 2025
Chambers and Partners’ Patent Litigation Guide 2025 is now available
The Patent Litigation 2025 Guide is now available! Organized by Chambers and Partners, Kasznar Leonardos has led the chapter in Brazil. Our … Chambers and Partners’ Patent Litigation Guide 2025 is now available
February 13, 2025
Kasznar Leonardos is ranked in Chambers and Partners Global Guide 2025
We are pleased to announce our recognition by the Chambers and Partners Global Guide 2025. Our firm has once again been recognized … Kasznar Leonardos is ranked in Chambers and Partners Global Guide 2025
January 31, 2025
Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024
We are honored to announce that Kasznar Leonardos has been recognized as a leading firm in Intellectual Property in South and Central … Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024